Preclinical
Identify potential failures earlier and inform alternate strategies to keep your program on track
Our Global Metabolomics Solution provides a high-resolution in vivo view of your molecule’s impact on preclinical models to help identify potential clinical risks and plan mitigations before you invest in expensive and time-consuming FiH trials.
Build confidence in the safety and efficacy of your program prior to FiH
See a clearer view of off-target effects and potential toxicity earlier in development
Identify pre-clinical biomarkers of pharmacodynamics, safety and efficacy with high-levels of clinical translatability
In vivo biological screening to guide therapeutic strategy
Study Design
Data Interpretation
Our Platform
Enlighten your research,
accelerate your discovery.
Contact Us
Talk with an expert
Request a quote for our services or more information on sample types and handling procedures, need a letter of support, or simply have questions about how metabolomics can advance your research.
Corporate Headquarters
617 Davis Drive, Suite 100
Morrisville, NC 27560
Mailing Address:
P.O. Box 110407
Research Triangle Park, NC 27709
+1 (919) 572-1711
+1 (919) 572-1721
International Headquarters
Metabolon GmbH
Zeppelinstraße 3
85399 Hallbergmoos
Germany
+49 89 99017752
